IDEVvsRXL
iShares Core MSCI International Developed Markets ETF against ProShares Ultra Health Care — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDEV | RXL | |
|---|---|---|
| Expense ratio | 0.040% | 0.95% |
| Assets | $32.2B | $99M |
| Net flow, 1 month | +$892M | +$1M |
| Net flow, 1 year | +$7.3B | +$3M |
| Return, YTD | +8.6% | +13.8% |
| Return, 1 year | +10.9% | +31.2% |
| Avg daily volume | 1.9M | 9K |
| Holdings | 2281 | 73 |
| Listed | Mar 21, 2017 | Feb 1, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS